Immunotherapy with checkpoint inhibitors is changing the face of oncology treatments for many tumors, and endometrial carcinoma may not be an exception. Several endometrial cancer groups from the molecular taxonomy are characterized by having an ultramutated/hypermutated genome, which could be the first Achilles' heel identified in this malignancy in decades. Clin Cancer Res; 22(23); 5623–5. ©2016 AACR.
See related article by Santin et al., p. 5682
from Cancer via ola Kala on Inoreader http://ift.tt/2fTNFMS
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου